Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 6 de 6
Filtrar
Mais filtros








Base de dados
Intervalo de ano de publicação
1.
Toxicol In Vitro ; 48: 318-328, 2018 Apr.
Artigo em Inglês | MEDLINE | ID: mdl-29432895

RESUMO

Regulation of DNA methylation plays a crucial role in biological processes and carcinogenesis. The formation of 5-hydroxymethylcytosine (5hmC) by oxidation of 5-methylcytosine (5mC) has been proposed as an intermediate of active demethylation. However, whether and how active demethylation is regulated by oxidative stress-related processes is not well understood. Here we investigated whether free oxygen radicals are capable of directly forming 5hmC and how this enhanced whole genome gene expression. We applied LC-MS/MS technology for the analysis of 5mC, 5hmC, 5-formylcytosine (5fC) and 5-hydroxymethyluracyl (5hmU) in HepG2 cells exposed to hydroxyl- and methyl radicals, formed by tert-butyl hydroperoxide (TBH) at multiple time points. We observed that TBH is able to induce a significant increase in 5hmC. A detailed evaluation of the hydroxymethylome using a combination of 5hmC-immunoprecipitation and microarrays resulted in the identification of highly dynamic modifications that appear to increase during prolonged oxidant exposure. Analyses of temporal gene expression changes in combination with network analysis revealed different subnetworks containing differentially expressed genes (DEGs) with differentially hydroxyl-methylated regions (DhMRs) in different regulatory kinases enriched with serine-threonine kinases. These serine-threonine kinases compromises MAPK14, RPSK6KA1, RIPK1, and PLK3 and were all previously identified as key-regulators in hepatocarcinogenesis and subject of study for chemotherapeutic interventions.


Assuntos
5-Metilcitosina/análogos & derivados , Regulação da Expressão Gênica/efeitos dos fármacos , Genômica/métodos , Estresse Oxidativo/efeitos dos fármacos , Proteínas Quinases/metabolismo , terc-Butil Hidroperóxido/toxicidade , 5-Metilcitosina/toxicidade , Animais , Redes Reguladoras de Genes/efeitos dos fármacos , Células Hep G2 , Humanos , Neoplasias Hepáticas Experimentais/induzido quimicamente , Neoplasias Hepáticas Experimentais/genética , Neoplasias Hepáticas Experimentais/patologia , Metaboloma , Análise em Microsséries , Proteínas Quinases/genética , RNA/genética , RNA/isolamento & purificação
2.
Nat Commun ; 8: 15102, 2017 04 25.
Artigo em Inglês | MEDLINE | ID: mdl-28440315

RESUMO

TET2 is a dioxygenase that catalyses multiple steps of 5-methylcytosine oxidation. Although TET2 mutations frequently occur in various types of haematological malignancies, the mechanism by which they increase risk for these cancers remains poorly understood. Here we show that Tet2-/- mice develop spontaneous myeloid, T- and B-cell malignancies after long latencies. Exome sequencing of Tet2-/- tumours reveals accumulation of numerous mutations, including Apc, Nf1, Flt3, Cbl, Notch1 and Mll2, which are recurrently deleted/mutated in human haematological malignancies. Single-cell-targeted sequencing of wild-type and premalignant Tet2-/- Lin-c-Kit+ cells shows higher mutation frequencies in Tet2-/- cells. We further show that the increased mutational burden is particularly high at genomic sites that gained 5-hydroxymethylcytosine, where TET2 normally binds. Furthermore, TET2-mutated myeloid malignancy patients have significantly more mutational events than patients with wild-type TET2. Thus, Tet2 loss leads to hypermutagenicity in haematopoietic stem/progenitor cells, suggesting a novel TET2 loss-mediated mechanism of haematological malignancy pathogenesis.


Assuntos
5-Metilcitosina/análogos & derivados , Proteínas de Ligação a DNA/genética , Neoplasias Hematológicas/genética , Células-Tronco Hematopoéticas/metabolismo , Taxa de Mutação , Proteínas Proto-Oncogênicas/genética , 5-Metilcitosina/metabolismo , 5-Metilcitosina/toxicidade , Idoso , Animais , Linhagem Celular Tumoral , Desmetilação do DNA , Análise Mutacional de DNA/métodos , Proteínas de Ligação a DNA/metabolismo , Dioxigenases , Epigênese Genética/genética , Regulação Neoplásica da Expressão Gênica , Neoplasias Hematológicas/mortalidade , Neoplasias Hematológicas/patologia , Humanos , Camundongos , Camundongos Knockout , Mutagênese/genética , Proteínas Proto-Oncogênicas/metabolismo , RNA Interferente Pequeno/metabolismo , Análise de Célula Única/métodos , Sequenciamento do Exoma/métodos
3.
Neurobiol Dis ; 96: 54-66, 2016 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-27576189

RESUMO

Environmental stress is among the most important contributors to increased susceptibility to develop psychiatric disorders. While it is well known that acute environmental stress alters gene expression, the molecular mechanisms underlying these changes remain largely unknown. 5-hydroxymethylcytosine (5hmC) is a novel environmentally sensitive epigenetic modification that is highly enriched in neurons and is associated with active neuronal transcription. Recently, we reported a genome-wide disruption of hippocampal 5hmC in male mice following acute stress that was correlated to altered transcript levels of genes in known stress related pathways. Since sex-specific endocrine mechanisms respond to environmental stimulus by altering the neuronal epigenome, we examined the genome-wide profile of hippocampal 5hmC in female mice following exposure to acute stress and identified 363 differentially hydroxymethylated regions (DhMRs) linked to known (e.g., Nr3c1 and Ntrk2) and potentially novel genes associated with stress response and psychiatric disorders. Integration of hippocampal expression data from the same female mice found stress-related hydroxymethylation correlated to altered transcript levels. Finally, characterization of stress-induced sex-specific 5hmC profiles in the hippocampus revealed 778 sex-specific acute stress-induced DhMRs some of which were correlated to altered transcript levels that produce sex-specific isoforms in response to stress. Together, the alterations in 5hmC presented here provide a possible molecular mechanism for the adaptive sex-specific response to stress that may augment the design of novel therapeutic agents that will have optimal effectiveness in each sex.


Assuntos
5-Metilcitosina/análogos & derivados , Epigênese Genética/efeitos dos fármacos , Hipocampo/metabolismo , Estresse Psicológico/induzido quimicamente , Estresse Psicológico/patologia , 5-Metilcitosina/toxicidade , Animais , Imunoprecipitação da Cromatina , Modelos Animais de Doenças , Epigênese Genética/genética , Feminino , Ontologia Genética , Hipocampo/efeitos dos fármacos , Masculino , Metilação/efeitos dos fármacos , Camundongos , Camundongos Endogâmicos C57BL , Fatores Sexuais
4.
Cancer Res ; 76(10): 3097-108, 2016 05 15.
Artigo em Inglês | MEDLINE | ID: mdl-27197233

RESUMO

Aberrant hypermethylation of CpG islands (CGI) in human tumors occurs predominantly at repressed genes in the host tissue, but the preceding events driving this phenomenon are poorly understood. In this study, we temporally tracked epigenetic and transcriptomic perturbations that occur in a mouse model of liver carcinogenesis. Hypermethylated CGI events in the model were predicted by enrichment of the DNA modification 5-hydroxymethylcytosine (5hmC) and the histone H3 modification H3K27me3 at silenced promoters in the host tissue. During cancer progression, selected CGIs underwent hypo-hydroxymethylation prior to hypermethylation, while retaining H3K27me3. In livers from mice deficient in Tet1, a tumor suppressor involved in cytosine demethylation, we observed a similar loss of promoter core 5hmC, suggesting that reduced Tet1 activity at CGI may contribute to epigenetic dysregulation during hepatocarcinogenesis. Consistent with this possibility, mouse liver tumors exhibited reduced Tet1 protein levels. Similar to humans, DNA methylation changes at CGI in mice did not appear to be direct drivers of hepatocellular carcinoma progression, rather, dynamic changes in H3K27me3 promoter deposition correlated strongly with tumor-specific activation and repression of transcription. Overall, our results suggest that loss of promoter-associated 5hmC in liver tumors licenses reprograming of DNA methylation at silent CGI during progression. Cancer Res; 76(10); 3097-108. ©2016 AACR.


Assuntos
5-Metilcitosina/análogos & derivados , Ilhas de CpG/genética , Metilação de DNA/efeitos dos fármacos , Proteínas de Ligação a DNA/genética , Neoplasias Hepáticas Experimentais/genética , Regiões Promotoras Genéticas/genética , Proteínas Proto-Oncogênicas/genética , 5-Metilcitosina/toxicidade , Animais , Carcinoma Hepatocelular , Diferenciação Celular , Histonas/metabolismo , Neoplasias Hepáticas Experimentais/induzido quimicamente , Neoplasias Hepáticas Experimentais/patologia , Camundongos , RNA Mensageiro/genética , Reação em Cadeia da Polimerase em Tempo Real , Reação em Cadeia da Polimerase Via Transcriptase Reversa , Células Tumorais Cultivadas
5.
PLoS One ; 8(9): e72993, 2013.
Artigo em Inglês | MEDLINE | ID: mdl-24066027

RESUMO

5-methylcytosine (5-mC) can be sequentially oxidized to 5-hydroxymethylcytosine (5-hmC), 5-formylcytosine (5-foC), and finally to 5-carboxylcytosine (5-caC), which is thought to function in active DNA cytosine demethylation in mammals. Although the roles of 5-mC in epigenetic regulation of gene expression are well established, the effects of 5-hmC, 5-foC and 5-caC on DNA replication remain unclear. Here we report a systematic study on how these cytosine derivatives (5-hmC, 5-foC and 5-caC) perturb the efficiency and accuracy of DNA replication using shuttle vector technology in conjugation with next-g sequencing. Our results demonstrated that, in Escherichia coli cells, all the cytosine derivatives could induce CT transition mutation at frequencies of 0.17%-1.12%, though no effect on replication efficiency was observed. These findings provide an important new insight on the potential mutagenic properties of cytosine derivatives occurring as the intermediates of DNA demethylation.


Assuntos
5-Metilcitosina/metabolismo , 5-Metilcitosina/toxicidade , Animais , Citosina/análogos & derivados , Citosina/metabolismo , Citosina/toxicidade , Metilação de DNA/efeitos dos fármacos , Escherichia coli/efeitos dos fármacos , Escherichia coli/genética , Sequenciamento de Nucleotídeos em Larga Escala , Oxirredução , Espectrometria de Massas por Ionização e Dessorção a Laser Assistida por Matriz
6.
Food Chem Toxicol ; 50(12): 4441-8, 2012 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-22975143

RESUMO

The effects of feeding six diets spiked with increasing levels of DON for 45 days to zebrafish (Danio rerio) on performance and liver gene biomarkers were investigated. In addition long term effects on fecundity, offspring larvae swimming activity and global DNA methylation in embryos were investigated. Zebrafish performance was not affected. Liver CYP1A mRNA levels were significantly higher in fish fed 2.0 ppm DON compared to the control group, 0.1, 0.5 and 1.5 ppm group. Gene transcripts of CuZn SOD and Cyclin G1 increased with increasing content of dietary DON. The percentage of 5-methylcytosine in embryos did not differ and was 7.0-7.1% across the groups. Fecundity showed a biphasic response pattern. Interestingly, fish fed 1.5 ppm DON had 22% higher fecundity compared to control. A trend towards increased larvae swimming activity was seen in the high DON group. Our data suggest that DON is detoxified in the liver through the phase 1 system resulting in a disturbance in the oxidative balance. We do not know if effects observed on fecundity and larvae swimming activity are attributed to a direct interaction of DON with the reproductive organ or secondary to the maternal/paternal liver oxidative imbalance.


Assuntos
Ração Animal/análise , Aquicultura , Tricotecenos/toxicidade , Peixe-Zebra/embriologia , Peixe-Zebra/crescimento & desenvolvimento , 5-Metilcitosina/toxicidade , Animais , Ciclina G1/genética , Ciclina G1/metabolismo , Citocromo P-450 CYP1A1/genética , Citocromo P-450 CYP1A1/metabolismo , Metilação de DNA/efeitos dos fármacos , Epigênese Genética/efeitos dos fármacos , Feminino , Larva/efeitos dos fármacos , Larva/crescimento & desenvolvimento , Modelos Lineares , Fígado/efeitos dos fármacos , Fígado/patologia , Masculino , Desintoxicação Metabólica Fase I , Estresse Oxidativo/efeitos dos fármacos , RNA/genética , Reação em Cadeia da Polimerase em Tempo Real , Reprodução/efeitos dos fármacos , Natação
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA